Drug Profile
Research programme: discodermolide analogues - Cellomics
Alternative Names: Discodermolide analogues research programme - Cellomics; NC 286Latest Information Update: 07 May 2007
Price :
$50
*
At a glance
- Originator Cellomics; University of Pittsburgh
- Class
- Mechanism of Action Apoptosis stimulants; Immunosuppressants; Tubulin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 07 May 2007 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 23 Jul 2003 Preclinical trials in Cancer in USA (unspecified route)